Spots Global Cancer Trial Database for Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Official Title: A Prospective, Observational Study to Assess the Real-World Usage and Outcomes of HyQvia in Patients With Multiple Myeloma (MM) Diagnosed With Secondary Immunodeficiency (SID)
Study ID: NCT05879757
Interventions
Study Description
Brief Summary: In this study, multiple myeloma participants with secondary immunodeficiency (SID) will be treated with HyQvia according to their clinic's standard practice. The study's main aim is to look into infusion parameters of HyQvia administration.
Detailed Description: This is a prospective, observational study of adults having multiple myeloma (MM) with SID treated with HyQvia as part of routine clinical care. This study will characterize the real-world infusion parameters of HyQvia administration. The study will enroll approximately 100 participants. Study data will be requested through participants' routine clinic visits and patient-reported outcome (PRO)s are voluntary. This multi-center trial will be conducted in selected European and Latin American countries. The overall time of this study is 38 months. Participants will make multiple visits to the clinic 12 days after last dose of study drug for a follow-up assessment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centro de investigaciones Clinicas Cordoba, Cordoba, , Argentina
Fakultni nemocnice Plzen, Pilsen, , Czechia
Vseobecna fakultni Nemocnice, Praha 2, , Czechia
UH Amiens CEDEX 1, Amiens Cedex 1, , France
CHU Dijon - Hopital du Bocage, Dijon, , France
Hopital Prive du Confluent, Nantes, , France
Hopital de la Source - CHR Orleans, Orleans, , France
CHU Bordeaux - Hopital Haut-Leveque, Pessac, , France
MHP-Muenchner Haematologiepraxis, Berlin, , Germany
Alexandra General Hospital, Athens, , Greece
G. Papanikolaou Hospital, Thessaloniki, , Greece
A.O.U.C Policlinico di Bari, Bari, , Italy
AOU Policlinico Rodolico San Marco, Catania, , Italy
Azienda Ospedale Universita Padova, Padova, , Italy
University of Padova, Treviso, , Italy
Lubin Region St. Jana z Dukli, Lublin, , Poland
Institutul Clinic Fundeni, Bucharest, , Romania
Ion Chiricuta Oncology Institute, Cluj Napoca, , Romania
Spitalul Clinic Municipal Filantropia Craiova, Craiova, , Romania
Clinical Emergency Hospital Sibiu, Sibiu, , Romania
Hospital Clinico San Carlos, Madrid, , Spain
H12 de Octubre, Madrid, , Spain
Hospital Universitari Son Espases, Palma, , Spain
SUS, Lund, Lund, , Sweden
Uppsala UH, Uppsala, , Sweden
Ankara University, Ankara, , Turkey
Antalya Training and Research Hospital, Antalya, , Turkey
Istanbul Universitesi, Istanbul, , Turkey
Medipol Istanbul University, Istanbul, , Turkey
Contact Details
Name: Study Director
Affiliation: Takeda
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
